ClearanceBrief
Recall Z-0765-06 ยท CDP Radioimmunoassay, Total Triiodothyronine

Ortho-Clinical Diagnostics

VITROS Immunodiagnostic Products Signal Reagent, Catalog No. 107 2693 --- an in vitro diagnostic for use on the VITROS Immunodiagnostics ECi/ECiQ System, which is used to screen and diagnose more than 40 diseases and conditions including cardiac disease, hepatitis (A, B, or C), thyroid disorders, HIV, and pregnancy.

DateApr 20, 2006 (initiated Mar 28, 2006)
StatusTerminated
ReasonFirm received complaints of biased results when using VITROS Signal Reagent, Lots 8350 and 8530. VITROS Signal Reagent is used with the VITROS Immunodiagnostic ECi/ECiQ laboratory system, and when used may produce inaccurate test results in some cases.
Root causeOther
ActionOrtho-Clinical Diagnostics sent "Urgent Product Correction/Recall Notification" letters, dated 3/28/06, to the customers via overnight mail. Ortho-Clinical Diagnostics issued a nationwide press release on 3/31/06. Patients who have had diagnostic testing performed for any of these medical conditions within the last 60 days and are concerned with their test results are recommended to discuss this matter with their physicians. Ortho-Clinical Diagnostics has advised laboratories, using this reagent, to contact the patient's physician if there are any concerns regarding previous test results. Cust
Quantity2000
DistributionMedical facilities nationwide and 1 foreign affiliate in Canada.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K964310VITROS IMMUNODIAGNOSTICS PRODUCT - TOTAL T3 REAGENT PACK (GEM .101) AND TOTAL CALIIBRATION (GEM.C010)
Johnson & Johnson Clinical Diagnostics, Inc., Nov 27, 1996